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The preservation of the female portion of livestock genetics has become an international priority; however, in situ conservation
strategies are extremely expensive. Therefore, eﬀorts are increasingly focusing on the development of a reliable cryopreservation
method for oocytes, in order to establish ova banks. Slow freezing, a common method for cryopreservation of oocytes, causes
osmotic shock (solution eﬀect) and intracellular ice crystallization leading to cell damage. Vitriﬁcation is an alternative method
forcryopreservationinwhichcellsareexposedtoahigherconcentration ofcryoprotectantsandfrozenwithanultrarapidfreezing
velocity, resulting in an ice crystal free, solid glass-like structure. Presently, vitriﬁcation is a popular method for cryopreservation
of embryos. However, vitriﬁcation of oocytes is still challenging due to their complex structure and sensitivity to chilling.
1.Introduction
Manydomesticbreedsoflivestockareexperiencingagradual
diminishment of genetic diversity; therefore, it is in the
interest of the international community to conserve the
livestock genetics. Ideally populations are saved as live
animals; however, this approach is expensive, and unless
the breed can be used for production, it is not likely to
succeed. Therefore, ex situ in vitro conservation strategies
are developed to cryopreserve animal genetic resources in
genome/gene banks to regenerate a particular population
in future [1, 2]. Although signiﬁcant progress has been
made in both semen and embryo cryopreservation of
several domestic species, oocytes are extremely sensitive to
chilling, and to date a standardized procedure has not been
established. Long-term storage of oocytes would develop of
ova banks, permitting female genetic material to be stored
unfertilized until an appropriate male germplasm is selected.
Successful cryopreservation of oocytes would also preserve
the genetic material from unexpectedly dead animals and
facilitate many assisted reproductive technologies [3–5].
2. Loss of FarmAnimalGeneticDiversity
In the last few decades, farm animal genetic diversity has
rapidly declined, mainly due to changing market demands
and intensiﬁcation of agriculture. Agriculture is moving
away from small production systems to large commercial
systems, and as a result, selection goals and production
environments are now very similar throughout the world.
Modern reproductive technologies have allowed a large
number of progeny to be produced from a single individ-
ual,andcontemporarytransporthasenabledthedistribution
of germplasm around the world rapidly and eﬃciently.
Livestock diversity has also been diminished by many
breeding programs carried out by national and international
companies, which place intense selection pressure on few
breeds [6].
According to the FAO, approximately 20 percent of the
world’s breeds of cattle, goats, pigs, horses, and poultry
are currently at risk of extinction, and at least one live-
stock breed has become extinct per month over the past
several years, resulting in its genetic characteristics being2 Veterinary Medicine International
lost forever [7]. It is imperative to conserve and maintain
animal genetic resources to ensure the ability to respond
to selection plateaus, consumer demand changes but more
importantly biosecurity, environmental, and food safety
risks by maintaining biodiversity and keeping alternative
and potentially useful genes available in the gene pool
[3, 8].
3. Strategies for Farm Animal
GeneticConservation
Increasing awareness on the reduction of breed diversity
has prompted global eﬀorts for conservation of threatened
breeds through launching organizations such as Rare Breeds
Canada, conferences like the Convention on Biological
Diversity, and programs such as the Canadian Animal
Genetic Resources. Eﬀorts have focused on conservation
of farm animal breeds for several reasons, for example, to
keep potentially useful genes and gene combinations, to take
advantage of heterosis, and to overcome selection plateaus,
as well as for cultural reasons, research, and food security.
Maintaining genetic diversity also provides insurance against
climate change, disease, changing availability of feedstuﬀs,
social change, selection errors, and unforeseen catastrophic
events such as Chernobyl where many local breeds’ diversity
became threatened [6, 9, 10].
The goals of conservation are to keep genetic variation as
gene combinations in a reversible form and to keep speciﬁc
genes of interest such as the Booroola fecundity gene in
sheep [11]. In order to achieve these goals several steps are
necessary. First an inventory must be taken to assess and
monitor the risk status of a breed in an ongoing basis by
examining the number of breeding males and females, the
overall breed numbers, the number of subpopulations, and
the trends in population size. The evaluation of stocks for
phenotype and genotype must be done to determine the
genetic distance of one group from another and the choice
of breeds for conservation [6].
3.1. In Situ Conservation. Ideally, populations should be
saved as live animals through in situ conservation programs;
however this approach needs extensive infrastructure and
management and thus is expensive [6]. Hence, ex situ
in vitro strategies have been developed to cryopreserve
animal genetic resources in a genome bank that creates
a global gene pool to manage the exchange of genetic
diversity or regenerate a population decades or centuries
later [1, 2]. The Convention on Biological Diversity rec-
ommended that ex situ conservation be complementary
to in situ conservation for farm animal genetic resources
[12].
3.2. Ex Situ Conservation. One of the major issues surround-
ing genome banks is the amount and type of material that
needs to be stored, which is a function of the intended future
use of the material [12]. In order to avoid inbreeding, a gene
bank of male and female genetics formed from the largest
number of individuals would be ideal [13]. Ex situ in vitro
conservation programs of livestock genetic resources have
focused eﬀorts on cryopreservation of gametes, embryos,
and somatic cells as well as testis and ovarian tissues,
eﬀectively lengthening the genetic lifespan of individuals in
a breeding program even after the death [1, 8].
3.2.1. Semen. Semen is one of the most practical means
of storing germplasm due to its abundant availability and
ease of application [1, 14]. Stored spermatozoa could be
introduced back into existing populations either immedi-
ately or decades or centuries afterwards. Stored frozen-
thawed semen from genetically superior males of threatened
livestock breeds could be used for artiﬁcial insemination
(AI) or in vitro fertilization (IVF) and has the potential
to protect existing diversity and maintain heterozygosity
while minimizing the movement of living animals [8,
15]. Breed reconstruction solely from semen is possible
through a series of back-cross generations; however, the
entire genetics of the original breed will not be recovered
[12].
Semen from most mammalian and a few avian species
has been successfully frozen in the past several years [14].
However, the protocols currently used to conserve semen are
still suboptimal and cannot be easily applied across species
[16]. First-service conception rates vary drastically between
diﬀerentbreedingprograms,butonaverageconceptionrates
are fairly high in cattle, pigs, goats, and sheep.
3.2.2. Embryos. Embryo cryopreservation allows the con-
servation of the full genetic complement of both dam
and sire and has tremendous opportunities for maintaining
heterozygosity and population integrity, but it is more
complex and costly procedure than semen cryopreservation.
Moreover, a large number of embryos would be required for
complete reconstruction of a population and are unlikely to
be available from donor females of endangered breeds [12].
Embryos of virtually all mammals have been successfully
frozen, thawed, and transferred to synchronized recipient
females in the past; however, embryos from species such
as swine or equine are much more cryosensitive compared
to bovine or ovine embryos. Currently, the widespread
use of embryo cryopreservation is limited to cattle, sheep,
and goats [17, 18]. Table 1 demonstrates embryo sensitivity
towards cryopreservation in diﬀerent species, developmental
stages, and origin. It is apparent that earlier and in vivo
derived embryos withstand cryopreservation better than
later stage and in vitro produced embryos. Therefore, the
current challenge is to develop a standardized protocol that
can be applied to embryos of diﬀerent species at various
developmental stages [3, 14, 19].
3.2.3. Oocytes. Oocytes are large cells, with a low surface to
volume ratio, surrounded by zona pellucida. Immediately
adjacent to the oocyte are corona radiata cells that have long
cytoplasmic extensions which penetrate the zona pellucida,
ending in oocyte membrane. These processes and gap junc-
tions are important in the metabolic cooperation between
the oocyte and surrounding layers of granulosa cells, which
formthecumulus-oocytecomplex(COC)duringthegrowth
phase.Veterinary Medicine International 3
Table 1:Diﬀerencesofanimaloocyteandembryocryopreservation
resistance among species, developmental stages, and origin.
More resistance Less resistance
Species Bovine, ovine Porcine, equine
Developmental
Stages
Morula, YBL, and
BL Hatched BL and oocytes
Origin In vivo derived
embryos
In vitro produced embryos,
micromanipulated embryos
YBL: young blastocyst; BL: blastocyst. Adapted from Pereira and Marques,
2008 [3].
Oocytes collected from slaughterhouse derived ovaries
are at the germinal vesicle (GV) stage in which the genetic
material is contained within the nucleus. Since this stage has
no spindle present, GVs are assumed to be less prone to
chromosomal and microtubular damage during cryopreser-
vation. However, oocytes can also be cryopreserved at the
metaphase II (MII) stage of maturation. During MII stage,
the cumulus cells surrounding the oocyte are expanded,
microﬁlaments of actin are involved in cell shape and
movements, and microtubules form the spindle apparatus
[20].
Oocytes collected by in vivo pickup or at slaughter
can be frozen for extended periods of time for subsequent
IVF to produce embryos. Oocyte banks would enlarge the
gene pool, facilitate several assisted reproductive procedures,
salvage female genetics after unexpected death, and avoid
controversy surrounding the preservation of embryos [4,
5]. Like semen, oocyte cryopreservation is beneﬁcial for
international exchange of germplasm, as it avoids injury and
sanitary risks involved in live animal transportation [3].
Oocytes are extremely sensitive to chilling, and the
technique is not as established as in semen or embryos, due
to the fact that oocytes typically have a low permeability
to cryoprotectants [16]. The major diﬀerences between
oocytes and embryos are the plasma membrane, presence
of cortical granules, and spindle formation at metaphase
II (MII) stage of meiosis [21]. To date, there has been no
consistent oocyte cryopreservation method established in
any species, although, there has been signiﬁcant progress
and oﬀspring have been born from frozen-thawed oocytes in
cattle, sheep, and horses [16, 22, 23]. During the process of
cryopreservation, oocytes suﬀer considerable morphological
and functional damage, although, the extent of cryoinjuries
depends on the species and the origin (in vivo or in vitro
produced). The mechanism for cryoinjuries is yet to be fully
understood, and until more insight is gained, improvement
of oocyte cryopreservation will be diﬃcult [3].
4. OocyteCryopreservation
4.1. Principles. Cryopreservation involves cells or whole
tissues preservation by exposure to subzero temperature in
LN2 (−196◦C) [16]. At such a low temperature, biological
activity is eﬀectively stopped, and the cells functional status
may be preserved for centuries [24]. However, several
physical stresses damage the cells at these low temperatures.
Intracellular ice formation is one the largest contributors to
cell death; therefore, freezing protocols use a combination
of dehydration, freezing point depression, supercooling, and
intracellular vitriﬁcation in an attempt to avoid cell damage
[25].
It is important to consider the nature and concentration
of the cryoprotectant(s) for preservation of germplasm in
any cryopreservation protocol. Dimethylsulfoxide (DMSO),
ethylene glycol (EG), or glycerol alone or in combination
protects the cells and tissues from freezing damage. More-
over,thecoolingrateandfreezingmethodarealsoimportant
factors to consider in preventing cryoinjuries of cells. Slow
freezing, using a controlled freezing curve, is commonly
used for cell cryopreservation; however, vitriﬁcation, in
whichhighconcentrationsofcryoprotectantsandultrarapid
freezing velocity are used, is gaining popularity due to its
promising success rates in certain species [3].
4.2. Cryoinjuries. During cryopreservation, the extent of
injury incurred in cells largely depends on the size and shape
of the cell, the permeability of the membranes, and the
quality of the oocyte. However, these factors vary between
species, developmental stage, and origin [26]. Although
oﬀspring have been born using frozen-thawed oocytes from
various species, the ability to support embryo development
following cryopreservation procedures is low. This may be
attributed to the susceptibility of oocytes to damage during
cooling and/or freezing and subsequent thawing because of
theircomplexstructure.Unfertilizedmammalianoocytesare
much larger therefore have small surface:volume ratio [21].
This makes dehydration and penetration of cryoprotectants
diﬃcult to achieve, which contributes to the complexity
in cryopreservation. Moreover, the plasma membrane of
oocyte diﬀers drastically from that in embryo. Following
fertilization, there is a rise in intracellular free calcium,
which modiﬁes the ionic strength and membrane potential
of the plasma membrane [27]. The submembranous poly-
merized ﬁlamentous actin concentration increases, and its
conformation changes, which facilitate the permeation of
water and cryoprotectants that promotes dehydration and
reduces intracellular ice crystal formation. Additionally, the
higher strength of the cell membrane increases the osmotic
tolerance during thawing and allows embryos to withstand
freezing and thawing better than oocytes [21].
Freezing immature, in vitro m a t u r e do ro v u l a t e do o c y t e s
often results in morphological and functional damage.
Although the speciﬁc molecular pathways disrupted during
freezing are not well understood, many ultrastructural
elements that are critical to maintenance and development
are damaged [28]. Postthaw oocytes often exhibit zona
pellucida or cytoplasmic membrane fractures, and cooling
oocytesfromapproximately37
◦Cto20
◦Corbelowcanresult
in various cytoskeletal and chromosomal modiﬁcations,
although some oocytes have the ability to fully or partially
repair themselves [20, 26]. The major adverse consequences
following freezing procedures are due to ice crystal for-
mation, osmotic injury, toxic eﬀects of cryoprotectants,4 Veterinary Medicine International
concentrated intracellular electrolytes, and chilling which
lead to zona fracture, alterations in intracellular organelles
andcytoskeleton[29,30].Strategiestoovercomethesemani-
festations involve reducing container volumes, increasing the
thermal gradient, altering the cell surface to volume ratio,
and the addition of substances to increase cryotolerance [3].
Theadditionofmoleculessuchasantifreezeproteins,sugars,
or antioxidants have been shown to stabilize the membrane
during cooling [4].
Various meiotic stages exhibit diﬀerent sensitivities to
freezing. Oocytes may be cryopreserved at immature GV
stage or at mature MII stage. Reports have shown that
freezing immature oocytes is ideal as there is no meiotic
spindle present and the genetic material is conﬁned within
the nucleus; however, immature oocytes are thought to be
more sensitive to anastomotic stress and have lower cell
membrane stability than MII stage oocytes [4, 31–33]. The
successofimmatureoocytecryopreservationlargelydepends
on the ability to preserve the structural and functional
integrity of the entire oocyte and cumulus cells surrounding
the oocyte. The gap junctions between oocytes and cumulus
cells play an important role in the maturation process
by providing nutritive substances that have a supportive
role during IVF [20]. It has been demonstrated that GV
stage oocytes stripped of cumulus cells exhibit deﬁcient
nuclear and cytoplasmic maturation [31, 34, 35]. However,
cumulus cells can also be an obstacle to the penetration of
cryoprotectants [30].
Cooling immature oocytes below 4◦C hinders the for-
mation of meiotic spindles and fertilization while exposing
matureoocytestocryoprotectants,andlowtemperaturescan
result in damage to the meiotic spindle, actin ﬁlaments, and
chromosomal dispersal and microtubule depolymerization
[20, 36]. Abnormalities in the meiotic spindle is related with
the loss of fertilization and embryo development as spindle
is crucial for completion of meiosis, second polar body
formation, migration of the pronuclei, and formation of the
ﬁrst mitotic spindle [37]. Spindle disorganization can result
in chromosomal dispersion, failure of normal fertilization,
and incomplete development [21, 38].
The microtubule, which is a component of the spindle,
is a cylindrical bundle, comprising 13 protoﬁlaments, a
heterodimer consisting of α and β-tubulin. Microtubules
begin from microtubular organizing centers at both poles
and anchor chromosomes at the kinetochores [21]. The
chromosomes align at the equatorial plane of the meiotic
spindles. A recent study in porcine oocytes found that
paclitaxel treatmentimprovedthe normality ofmicrotubules
by strengthening the bond between α and β-tubulin and
improved the developmental ability of vitriﬁed MII oocytes
[36, 39].
Regardless the stage of oocytes, DNA is damaged during
cryopreservation [20]. Cryopreserved oocytes have altered
distribution of cortical granules, increased polyspermy, and
zona hardening due to premature cortical granule release,
which deters the entry of sperm and thus fertilization [3, 39–
42]. The use of intracytoplasmic sperm injection (ICSI)
overcomes the eﬀects of zona hardening. In 1995, using ICSI
for frozen-thawed oocytes resulted in higher fertilization
Table 2: Comparison of oocyte and embryo cryopreservation
methods.
Freezing procedures
Conventional slow-freezing
method Vitriﬁcation
(1) Standard 0.25ml straws
(1) Several devices for loading
embryos and oocytes
(conventional straws, open
pulled straw, cryoloop, cryoleaf,
cryotop, etc.)
(2) Low cryoprotectant
concentration
(2) High cryoprotectant
concentration/ reduced volume
and time with vitriﬁcation
solution
(3) Seeding at −5t o−7
◦C,
controlled slow cooling (0.1
to 0.3
◦C/min)
(3) Ultra-rapid cooling rates
(−2500
◦C/min or 20000
◦C/min
using OPS and cryoloop)
(4) Plunging at −30 to
−70
◦C and storage in
liquid nitrogen (−196
◦C)
(4) Plunging into liquid nitrogen
(−196
◦C)
Adapted from Pereira and Marques, 2008 [3].
rates than IVF; however, in animals the use of ICSI is not
as established as IVF and thus requires further investigation
[21, 43].
4.3. Freezing Procedures. Currently, two main methods for
cryopreservation of oocytes are slow freezing and vitriﬁca-
tion. With the exception of cryoprotectants concentration
and cooling rate, these two methods diﬀer slightly with
regards to storage, warming, and rehydration [26]. Table 2
compares conventional freezing and vitriﬁcation methods
for oocyte and embryo cryopreservation [3].
Conventional slow freezing was introduced ﬁrst and is
currently the gold standard for cryopreservation of embryos.
This method typically involves the use of a single cryopro-
tectant in low concentrations (approximately 1 to 2M) to
minimize chemical and osmotic toxicity and attempts to
maintainabalancebetweenthevariousfactorsthatinﬂuence
cell damage [3]. During the controlled cooling rate, water is
exchanged between the extracellular and intracellular ﬂuids
without serious osmotic eﬀects [26]. However, during slow
cooling, extracellular water precipitates as ice resulting in ice
crystal formation. Slow freezing gives acceptable results for
oocytes of species that are not sensitive to chilling such as
cat [44], human [45], and mouse [46]. However, bovine and
porcine oocytes are more sensitive to chilling and yield poor
results following slow cooling [4].
The physical deﬁnition of vitriﬁcation is the glass-like
solidiﬁcation of solutions at low temperatures, without the
formation of intracellular ice crystals. During this method of
cryopreservation, ice crystal formation is prevented due to
the viscosity of the high concentrations of cryoprotectants
(approximately 7 to 8M) used in vitriﬁcation media that
makes water solidify without expansion [30]. Cells undergo-
ing vitriﬁcation are frozen at an extremely rapid cooling rate
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compared with slow freezing [47]. Although, some transi-
tional and very short freezing of the solutions can occur dur-
ingwarmingfollowingvitriﬁcation,thisisgenerallyharmless
to the oocyte. However, the high concentrations make
cryoprotectants toxic to the cells. As a result, oocytes can
only be exposed to a minimal volume of vitriﬁcation media
for a very short time, that is, <1m i n[ 3]. Extensive research
in the past 20 years has resulted in new approaches which
have created an acceptable balance between the positive and
negativeeﬀectsofvitriﬁcation.Ultra-rapidcoolingrateshave
allowed decreased cryoprotectant concentrations and have
made vitriﬁcation an extremely competitive alternative to
conventional slow freezing [26]. Presently, vitriﬁcation is a
popular method for cryopreservation of many diﬀerent cell
types, tissues, and organs; however, the extent of cryoinjury
anddevelopmentalratesarehighlyvariabledependingonthe
species [3, 20].
Despite the fact that slow freezing is the most widely
used cryopreservation technique, vitriﬁcation is a viable and
promising alternative that is increasingly becoming more
attractive to the commercial sector. Many reports comparing
conventional embryo slow freezing and vitriﬁcation have
reportedeitherequalorbetterinvitroorinvivosurvivalrates
following vitriﬁcation [48, 49]. Vitriﬁcation of oocytes and
embryos has been tested in several species with good results,
does not require costly coolers or special skill, and can be
performed fairly quickly [30, 50–52]. It has been suggested
that with time, conventional slow freezing will be replaced
entirely by vitriﬁcation techniques [26].
4.4. Cryoprotectants. Cryopreservation strategies are based
on two main principles: cryoprotectants and cooling-
warming rates [26]. Because water is not very viscous, it can
only be vitriﬁed by extremely rapid cooling of a small sample
or using high concentrations of cryoprotectants [53]. Cry-
oprotectants such as glycerol, dimethyl sulfoxide (DMSO),
and ethylene glycol (EG) are small molecules that penetrate
cells and limit the amount of intracellular and extracellular
water that converts into ice during cooling. However, cells
do have a biological limit to tolerate the concentration of
cryoprotectants. It is imperative to maximize the cooling
rate while minimizing the concentration of cryoprotectants
during vitriﬁcation [53].
Cryoprotective solutions are typically prepared in
buﬀeredmedia(e.g.,TCM-199)withastablepHbetween7.2
and 7.4 [54]. Cryoprotectants are compounds used in cry-
oprotective solutions to achieve cellular dehydration and to
avoid intracellular ice crystal formation upon freezing. Typ-
ically combinations of cell permeating and nonpermeating
cryoprotectants are used. Low molecular weight permeating
cryoprotectants such as glycerol, EG, and DMSO are small
molecules that enter the cell, form hydrogen bonds with
intracellular water molecules, and lower the freezing tem-
perature, preventing crystallization. Low molecular weight
non-permeating cryoprotectants such as sucrose, glucose,
trehalose, and fructose remain extracellular and draw free
water out of the cell by osmosis, resulting in intracellular
dehydration [3]. The addition of sugars to an EG-based
media can strongly inﬂuence the vitriﬁcation properties of
the solution and assist in stabilizing membrane structures
[55]. Disaccharides act as osmotic buﬀers to reduce osmotic
shock and the toxicity of EG by decreasing the con-
centration required to achieve successful cryopreservation
[53].
High molecular weight non-permeating polymers or
macromolecules are commonly used to reduce the amount
of intracellular cryoprotectants necessary for vitriﬁcation,
reducing the toxicity of the solution. Polymers protect zona
pellucidaagainstcracking.Themajorityofsolutionsusedfor
oocyte vitriﬁcation contain a macromolecular component
of fetal calf serum or bovine serum albumin. Other macro-
molecules used in vitriﬁcation media include polyethylene
glycol, polyvinylpyrrolidone, Ficoll, and polyvinyl alcohol
[3].
Theadditionofnonpermeatingpolymers,acombination
ofmorethanonecryoprotectant,andtheirstepwiseexposure
minimizes the toxic eﬀect of cryoprotectants on cells.
Additionally, it has been shown that adding cells to a lower
concentration of EG before transferring them to a higher
concentration disaccharide mixture can reduce the toxic
eﬀect of cryoprotectants [53].
4.5. Cooling Rate. It has been reported that a cooling rate
of approximately 2500
◦C/min can achieve a vitriﬁed state
[54]. However, using a suitable carrier system such as the
open pulled straw, a cooling rate of 20000
◦C/min can be
achieved [50]. The main reasons for increasing cooling and
warming rates are to avoid chilling injury and to decrease
the concentration of cryoprotectants in solution [53]. By
passing cells through the critical temperature zone (15 to
−5◦C) quickly, water moves out of the cells and freezes
extracellularly [20]. This prevents chilling injury to the
intracellular lipid droplets, lipid containing membranes, and
the cytoskeleton [30].
As cells are immersed in LN2, it is warmed, resulting
in extensive boiling. Evaporation occurs, and a vapor
coat surrounds the cells and creates an insulative layer
that decreases the temperature transfer and cooling rate.
Minimizing the volume surrounding the cell, avoiding LN2
vapor formation, and establishing direct contact between
the cryoprotectant and the LN2 all assist in increasing the
cooling and warming rates during vitriﬁcation of cells [53].
However, techniques based on the direct contact of LN2
and the medium containing the oocytes may be a source of
contamination.Theseriskscanbeminimized byusingsterile
LN2 for cooling then wrapping the oocytes in a hermetic
container before storage; however, this procedure may be too
complex for everyday application [30].
T h ed e v e l o p m e n to fs p e c i a lc a r r i e r ss u c ha st h eo p e n -
pulled straw [56], microdrops [57], cryoloop [58], ﬂexipet-
denuding pipette [59], electron microscopic copper grids
[60], hemistraw system [61], small nylon coils [62], nylon
mesh [63], and cryotops [64] has achieved higher cooling
rates while permitting the use of less toxic and less con-
centrated solutions [20]. These carriers shorten the time
of exposure with the ﬁnal cryoprotectant before cooling
and after warming, and the small volume of solution
prevents heterogeneous ice formation [30]. Consequently,6 Veterinary Medicine International
the promising results have led to new method to increase the
cooling rate using supercooled LN2 [53, 65].
In order to avoid cell injury and death during vitriﬁca-
tion,icecrystalformationneedstobepreventedbyremoving
as much of the intracellular water as possible. However, the
removal of excessive water results in cell injury and death
through the eﬀect of the highly concentrated intracellular
environment on membranes, referred as “solution eﬀect”
[53].
4.6. Criteria to Assess the Quality of Frozen-Thawed Oocytes.
There are several diﬀerent methods used to test the via-
bility and extent of chilling injuries of oocytes following
cryopreservation. Typically, the primary criteria used to
assess postthaw viability of oocytes are the presence or
absence of degeneration or cytoplasmic vascularisation or
zona pellucida fractures [66]. The membrane damage was
evaluated using probes to indicate the integrity of the plasma
membrane [4]. Recent studies examined the meiotic spindle
in human oocytes, using a polarized microscope apparatus,
which allows the visualization of the polymerisation of the
meiotic spindle following warming. However, this technique
is diﬃcult in domestic animals due to their high cytoplasmic
lipid content, which hinders spindle examination. Therefore,
the oocytes of domestic animals are typically examined
through invasive methods such as ﬂuorescence microscopy
and biochemical or molecular analyses [66].
Current research is focusing on the development of new
noninvasive evaluation techniques or markers. For example,
ifthegeneexpressionofthecumuluscellscouldbecorrelated
with developmental rates, gene expression could be used
as a marker for oocyte quality before freezing, helping to
select the oocytes most suitable for cryopreservation [67].
Moreover, determining the volumetric response of matured
oocytes to changes in osmolarity during preparation for
cooling would be another non-invasive response to oocyte
evaluation. This may assist in decreasing the toxic and
osmotic eﬀects of cryoprotectants on oocytes. Measuring the
volumetric response to increasing cryoprotectants concen-
trations permits a precise estimate of the ideal timing and
concentration of cryoprotectants exposure [66].
Although the viability of frozen-thawed oocytes has been
tested using in vitro fertilization and ICSI, the best way to
evaluate the capacity of embryos derived from cryopreserved
oocytes is to produce viable oﬀspring [68]. Currently there
have been live oﬀspring born from cryopreserved oocytes in
humans [69] and bovine [70].
5.VitriﬁcationofOocytes
Over the years there has been considerable eﬀort focused
on reducing the time of freezing procedures and eliminat-
ing the need for programmable cell freezers required for
conventional slow freezing. Moreover, equilibrium freezing
may not be the most advantageous method to cryopreserve
oocytes as they are damaged due to long exposure to
temperatures near 0◦C[ 20]. Vitriﬁcation is the alternative
method of cryopreservation which uses an ultra rapid
coolingrate,eliminatingtheneedforprogrammablefreezing
equipment. Furthermore, the vitriﬁcation technique uses
high concentrations of cryoprotectants which avoids water
precipitation, preventing intracellular ice crystal formation
[3]. In the last several years, almost all advancements in
oocyte cryopreservation have been made using vitriﬁcation
techniques,and their useforoocyteandembryocryopreser-
vation will undoubtedly increase in the future [26].
In 1985, vitriﬁcation of mouse embryos emerged as an
alternative approach to traditional slow freezing methods
[71]. However, the ﬁrst successful mouse embryo vitriﬁca-
tion was documented in 1993 [72]. Bovine oocytes are able
to develop to the blastocyst stage following high cooling
rates [65], and pregnancies have been achieved following
vitriﬁcation of human oocytes [73, 74].
Many variables in the vitriﬁcation process exist that can
profoundly inﬂuence the survival rate of oocytes. The extent
of injury and the diﬀerences in survival and developmental
rates are variable depending on the species, developmental
stage, and origin [3]. The type and concentration of the
cryoprotectant, the temperature of the vitriﬁcation solution
at the time of cell exposure, and the duration of exposure
to the ﬁnal cryoprotectant before plunging in LN2 are
importantfactorstoimprovethesurvivalrates.Theexposure
time of oocytes and embryos to cryoprotectants may be
shortened,ortheyareoftenpre-equilibratedinavitriﬁcation
solution containing a lower concentration of permeating
cryoprotectantstoavoidanyanticipatedtoxicshockresulting
from exposure to higher concentrations of cryoprotectants
in a ﬁnal vitriﬁcation solution [75–77]. However, it is not
yet clear whether a pre-exposure to lower concentrations of
vitriﬁcation is necessary and, if so, what is the optimal time
for such exposure. During warming, the main biophysical
factor causing cellular disruption is osmotic injury, which
can occur during the removal of penetrating cryoprotectants
from the cell. The ideal time for oocytes to be suspended in
warming medium is still uncertain. If the time is insuﬃcient,
cryoprotectants may not be completely removed; however if
lefttoolong,osmoticswellingcanoccur,especiallygiventhat
cryopreserved cells are much more sensitive than nonfrozen
cells [78].
Moreover, the type of cryodevice used for vitriﬁcation
inﬂuencesthecoolingrateandsizeofthevaporcoat.Oocytes
from humans [79–81], pigs [82], horses [83], sheep [58, 84],
cattle [85], and buﬀalo [86, 87] have developed in vitro
following cryopreservation using cryotop. Although results
are inconsistent, meiotic stage is also thought to contribute
to oocyte survivability following cryopreservation [32, 88–
92]. The ideal strategy to improve the success of vitriﬁcation
includes increasing the speed of thermal conduction and
decreasing the concentration of cryoprotectants [53].
5.1. Bovine. Although the cryopreservation of bovine
oocytes remains a challenge, some of the most encouraging
results among domestic animals have been obtained in the
bovine, where oﬀspring have been born from immature
and mature vitriﬁed oocytes following IVF and culture
[93, 94]. Vajta [82] reported a 25% blastocyst rate on day
8 following vitriﬁcation using open-pulled straw, thawing,
IVF, and culture in vitro. Bovine oocytes are much moreVeterinary Medicine International 7
cryostablethanporcineoocytesduetolesslipidcontentsand
intracellular lipid droplets and vesicles, thus porcine oocytes
are much more diﬃcult to successfully cryopreserve than
bovine[95].GVstagebovineoocyteshavehomogenouslipid
droplets that show little change following cooling; however
their large size and low surface: volume ratio makes it
diﬃcult for water and cryoprotectants to move across the
plasma membrane [96].
In order to obtain higher blastocyst formation and
healthy oﬀspring following vitriﬁcation, good quality bovine
oocytes should be used. Oocytes matured in vivo demon-
strate a signiﬁcantly higher maturation rate and blastocyst
formation than those matured in vitro [97, 98]. Oocytes
obtained from large growing follicles that are not in the
presence of a dominant follicle and have large enough diam-
eters to be considered competent also assist in improving
cryopreservation rates of bovine oocytes [20]. Moreover, a
partial removal of cumulus cells several hours after the onset
of IVM may facilitate cryoprotectant penetration while still
maintaining supportive and nutritive roles [20].
Although modifying cryopreservation methods to ﬁt
the cell type being cryopreserved may be more preferable,
modifying cells to ﬁt the cryopreservation procedure has also
been proposed to improve survival rates [96]. The cleavage
rate and 8-cell embryo stage improved signiﬁcantly after
treating bovine oocytes with cholesterol-loaded cyclodextrin
[99]. The centrifugation of mature bovine oocytes for partial
removal of cytoplasmic lipid droplets prior to vitriﬁcation
reduced the incidence of polyspermy [100]. Modifying the
lipid content, removing serum albumin from media, and the
addition of a membrane stabilizer such as trehalose to the
cytoplasm are worth investigating factors [96].
5.2. Other Farm Animals. Although oﬀspring have been
produced after the transfer of embryos from frozen-thawed
oocytes in several species [45, 101], the overall success
rate has been low, primarily due to the decreased rate
of fertilization following freezing and thawing [54]. Sim-
ilar to embryos, porcine oocytes are highly sensitive to
low temperatures. Consequently there is yet to be viable
piglets born from cryopreserved oocytes in spite of blasto-
cyst development following cryopreservation of MII stage
oocytes [36, 82]. The meiotic spindle of porcine oocytes is
extremelysensitivetocryopreservation,resultinginimpaired
development at meiosis-II [21]. However, the main cause
of poor survival following vitriﬁcation can be attributed
to the high intracellular lipid content in porcine oocytes.
Porcine GV oocytes contain 2.4-fold more lipid droplets
than bovine oocytes [102]. Additionally, dark homogenous
lipid droplets as well as grey ones with electron-lucent
streakschangemorphologicallyfromroundtosphericalwith
lucent streaks during cooling [3, 95]. However, the removal
of cytoplasmic lipid droplets using delipidation increases
their freezing tolerance [103]. A recent study combined
the removal of cytoplasmic lipid droplets with microtubule
stabilization and found that vitriﬁed porcine IVM MII stage
oocytes could develop to the blastocyst stage and maintain
the ability to develop into fetuses [36]. Furthermore, the use
of cholesterol-loaded cyclodextrin to increase the cholesterol
content of oocyte membranes has improved cryotolerance
[96].
In equine, immature oocytes undergo signiﬁcant damage
during controlled freezing. Less than 16% reach MII stage
during post thaw maturation, which is less than the 50−80%
of non-cryopreserved oocytes [104, 105]. Although MII
rates are higher in equine oocytes that have been vitriﬁed
(28−46%), approximately 50% of oocytes reaching MII
stage exhibit spindle abnormalities and poor developmental
competence [28, 106, 107]. Much of the damage to equine
oocytes is on the mitochondria and gap junctions between
the oocyte and surrounding cumulus-corona radiata cells
and these interactions are critical for successful maturation
and developmental competence [34].
Currently, a limited number of studies have been done
on the vitriﬁcation of small ruminant oocytes, especially
in sheep, where poor developmental rates are obtained
following immature [108, 109]a n dm a t u r e[ 58]o o c y t e
vitriﬁcation. Poor ovine oocyte cryopreservation has been
attributed to the damage to enzymes such as mitogen-
activated protein (MAPK) kinase, critical for oocyte matura-
tion and subsequent embryo development. The denudation
of immature ovine oocytes prior to vitriﬁcation increased
survival and maturation ability, however, the process also
decreases maturation promoting factor (MPF) and MAP
kinase levels, which inﬂuence meiotic and mitotic cell cycle
regulation and developmental competence [31]. Current
investigations are focusing on the factors inﬂuencing the
ability of vitriﬁed ovine oocytes to undergo IVF and develop
further.
Despite the recent advancements, the cryopreservation
of oocytes of most mammalian species remains a challenge
due to their complex structure. Although there has been
increasing number of publications regarding vitriﬁcation of
oocytes, more research is required to further elucidate the
species-speciﬁc mechanisms inﬂuencing poor survivability
following vitriﬁcation. Moreover, additional examination
of modifying oocytes to ﬁt the cryopreservation technique
may be necessary, especially in species whose oocytes have
extremely high lipid contents.
6. Conclusions
The loss of farm animal genetic resources is occurring
at alarming rates across the globe. Traditions, cultural
values, and safeguarding diversity for an unpredictable
future are all driving forces for genetic conservation, which
is a global responsibility. Preserving live animals permits
further evolution of breeds; however, in many cases, in
situ conservation strategies are not practical or adequate.
Therefore, establishing genetic resource banks to conserve
the current genetic status would provide a crucial interface
between ex situ and in situ conservation strategies.
Cryopreservation of oocytes is a crucial step for the
conservation of the female portion of genetics; however
despitedecadesofresearch,itremainsachallengeinvirtually
all species due to the complex structure of the oocyte.
Conventional slow freezing commonly leads to intracellular
icecrystallizationandcelldamage,andalthoughvitriﬁcation8 Veterinary Medicine International
of bovine oocytes is gaining popularity, it is still challenging
due to oocyte’s complex structure and sensitivity to chilling.
Vitriﬁcation is a relatively simple and inexpensive method of
cryopreserving oocytes; however, despite the tireless eﬀorts
over the past 20 years, vitriﬁcation has yet to achieve
convincing results capable of widespread application. It is
critical that researchers achieve more consistent results and
establish a “universal” protocol that can be applied for
the cryopreservation of oocytes at diﬀerent developmental
stages.
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